The NewYork-Presbyterian/Weill Cornell Center for Digestive Care integrates our renowned expertise, proven procedures and advanced therapies for treatment of digestive diseases with the successful multidisciplinary model of care.
The Center for Digestive Care is supported by gifts from the Leona M. and Harry B. Helmsley Charitable Trust.
The Center for Digestive Care offers a comprehensive set of services spanning the entire spectrum of digestive ailments, from leading-edge treatments to nutrition. Our world- class, multidisciplinary care team designs a unique care plan for each patient, in consultation with patients and their families. The Center promotes conservative treatment plans and views surgery as a last resort.
The Center for Digestive Care builds on our current programs, which span the entire spectrum of digestive disorders and treatments. The Jay Monahan Center for Gastrointestinal Health, The Jill Roberts Center for Inflammatory Bowel Disease and The Center for the Study of Hepatitis C are dedicated to specialized clinical care, education and research. These coordinated centers were founded on principles of patient-centered care.
The Monahan Center focuses on prevention, screening, treatment, support, research, and education for individuals who have or are at risk for developing gastrointestinal cancers. These cancers include those of the colon, rectum, pancreas, esophagus, liver, bile duct, gallbladder, stomach, small intestine, and anus.
The IBD Center is dedicated to the research and treatment of inflammatory bowel disease (IBD), a condition affecting more than 1 million Americans that most often results from two specific diseases: ulcerative colitis and Crohn's disease.
The Center for Colon and Rectal Surgery focuses on new aspects of treatment of Crohn's disease, ulcerative colitis, colon and rectal cancer, diverticular diseases, and all aspects of anorectal diseases. In addition, the center has particular focus on laparoscopic and endolumenal management of colon and rectal diseases.
The Center for the Study of Hepatitis C is currently managing one of the most robust and diversified Hepatitis C clinical trials in the United States with promising developments towards new HCV treatments. This collaborative program, established in 2000, calls on the expertise resident at three New York area institutions: Weill Cornell Medical College, NewYork-Presbyterian Hospital, and The Rockefeller University.
The Hepatitis C program features one of the world's leading laboratories in the study of the molecular, cellular, and structural biology of the hepatitis C virus, as well as the interactions between the virus, cells of the liver, and the immune system.
The Center is continually redefining and expanding training in digestive diseases, developing new medical-surgical fellowships and sponsoring multidisciplinary grand rounds, while supporting case conferences, tumor boards, and journal clubs that incorporate training with patient care.
The Center sponsors and is affiliated with a number of exciting courses, annually offered through NewYork-Presbyterian Hospital and the Weill Cornell Medical College. Some of those courses include:
September 19 & December 12, 2009. Laparoscopic Colon Surgery Course 2009: one-day hands-on laparoscopic colon surgery course designed for practicing surgeons or post-graduate fellows who are interested in gaining practical experience. The course consists of brief instructions and discussion followed by a hands-on laboratory session. During the laboratory session, participants will perform a fully laparoscopic right colectomy and left colectomy using fresh cadavers under the guidance of the faculty.
October 13, 2009 - May 25, 2010. The Center for the Study of Hepatitis C offers a weekly seminar series covering a broad range of topics including research and treatment of Hepatitis C and other viruses and general topics in virology, molecular biology and cell biology. Target audience includes physicians, primarily those with a specialty in hepatology, virology and/or infectious disease as well as researchers in virology, HCV and infectious disease from the tri-institutional group as well as other local, national and international institutions.
September 2009. The Jay Monahan Center for Gastrointestinal Health has joined with the American College of Obstetricians and Gynecologists (ACOG) in New York to form ACOG NY's Colorectal Cancer Task Force. In September 2009, ACOG NY and the Monahan Center hope to complete a colorectal cancer section for ACOG's Focus on Female Cancers education binder, which will be sent to OB/GYN's in New York State.
September 15 - 16, 2008. The First World Congress on Interventional Therapies for Type 2 Diabetes.
December 15 - 16, 2008. NewYork-Presbyterian Second Annual International NOTES Conference: This annual course addressed the newest developments in Natural Orifice Translumenal Endosocpic Surgery (NOTES), single port and endolumenal surgical procedures, while giving perspective to the past year. Procedures conducted within and through natural body orifices have the potential to offer direct anatomical access, virtually painless surgery, and minimal recovery time.
April 20, 2009. The Jay Monahan Center for Gastrointestinal Health collaborated with the Felix Burda Foundation in Munich, Germany to sponsor the First Transatlantic Symposium "To Increase Colorectal Cancer Screening." This effort is the beginning of an international collaboration to increase colorectal cancer screening worldwide.
June 18, 2009. The Fourth Annual Digestive Disease Week Update 2009: The Changing World of Crohn's and Colitis Interactive Case Discussion.
The NewYork-Presbyterian/Weill Cornell Center for Digestive Care combines our renowned expertise, proven procedures, and advanced therapies for treatment of digestive diseases into a seamlessly integrated patient- focused care model. The Center represents one of the first top-tier digestive programs in the US to implement this patient-centric care model.
The Center unites specialists from various departments and disciplines into four major clinical areas focused on the digestive system:
Each clinical area is staffed with top-tier adult and pediatric gastroenterologists, surgeons, oncologists, nurses, and critical support staff, including radiologists, pathologists, genetic counselors, and nutritionists. This team of specialists works collaboratively to evaluate all relevant treatment options and to develop an integrated, coordinated plan of care for every patient.
Within each clinical area, highly skilled nurses guide every patient through each step of diagnosis, treatment, and recovery. These care coordinators also facilitate the referring physician's interaction with the care team at NewYork-Presbyterian/Weill Cornell, providing timely information on recommended treatment plans and patient progress to patients, their families, and their primary doctors.
Jeffrey Milsom, M.D. Executive Director, Center for Digestive Care
The care team at the Center for Digestive Care builds upon our world-class clinicians and physician scientists at NewYork-Presbyterian/Weill Cornell. Twenty-eight physicians from our Center are recognized as Top Doctors by Castle Connolly - more than any other digestive service or program in the greater New York region. Our clinicians and researchers are at the forefront of clinical digestive care and development of new innovations that treat digestive conditions.
Our clinical team is supported by our Clinical Program Coordinators, a team of highly-skilled NPs expert in digestive care, and compassionate Patient Navigators to support patients while at our facility and beyond. This team guides Center patients through each step of diagnosis, treatment, and recovery.
Coordinators also facilitate interactions with external physicians as they collaborate with the Center care team during their patients treatment. This integrated, collaborative model provides an opportunity for consultation on challenging digestive cases in a multidisciplinary forum, improving patient outcomes.
Multidisciplinary collaborations allow us to make extraordinary breakthroughs in clinical care and in research, leading to the development of exciting new drugs, therapies, and technologies. Just as our clinical care model is designed to converge specialists from many fields of medicine to provide the best treatment for patients, our research program brings together world renown researchers with exciting and diverse scientific backgrounds.
The Center's affiliation with Weill Cornell Medical College, and several other leading universities and institutions across the greater New York region provides a robust foundation on which to build significant research collaborations. The cross pollination of ideas that results from these collaborations brings new ideas and new solutions to digestive system problems. And these research-based solutions take many forms, from new drugs and procedures to new surgical tools and implantable devices.
New tools and medical devices developed at the Center are enabling physicians to perform an increasing number of procedures endolumenally. This means patients can have outpatient procedures requiring only local anesthesia and minimal at-home recovery where just a year ago those same patients would require open surgeries and week-long hospitalization. Strong partnerships with industry are ensuring these devices become available to patients and their physicians nationally and internationally, not just in Center operating rooms.
The Leona M. and Harry B. Helmsley Surgical Suite consists of four operating rooms incorporating the most advanced surgical, endoscopic and radiological technology. Each surgical suite features live feed, multi-imaging video, giving care teams instantaneous access to critical data, ranging from capsule endoscopy to real-time medical opinion from experts around the world.
In our endsocospy suite, gastroenterologists are pioneering novel applications using state-of-the-art technologies to diagnose and treat a variety of complex disorders.
Multidisciplinary collaborations allow us to make extraordinary strides in research, technology, and therapies, leading to breakthroughs in treatment options.